Home

Suvretta Capital Management reported a 5.2% stake in Compass Therapeutics CMPX · 7,149,493 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
5.2%
Last report
First report
Shares held
7,149,493 sh
Class
Common Stock, $0.0001 par value per share
Event date
25/06/30
Filed
25/08/13

First 5%+ report · 5.2% stake

Compass Therapeutics trades, last 26 weeks

What else happened in Compass Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Suvretta Capital Management's other 5% stake reports

  • Montanova Capital

    5% stakeVeradermics

    8.8% stake

    Filed 08/21

  • Montanova Capital

    5% stakeAbeona Therapeutics

    0.9% stake

    Filed 08/14

  • Montanova Capital

    5% stakeMonte Rosa Therapeutics

    4.2% stake

    Filed 08/14

  • Montanova Capital

    5% stakeFulcrum Therapeutics

    5.5% stake

    Filed 08/14

  • Montanova Capital

    5% stakeInflaRx

    15.6% stake

    Filed 08/14